Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chronic Myeloproliferative Disorders|Gestational Trophoblastic Tumor|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Nausea and Vomiting|Neuroblastoma|Ovarian Cancer|Testicular Germ Cell Tumor
Interventions: DRUG: Aprepitant|DRUG: Cyclophosphamide|DRUG: Dexamethasone|DRUG: Granisetron hydrochloride
Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)